Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Due to system maintenance, login and edit functionaility is currently unavailable

Sara Gandolfi, M.D.

Concepts (63)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma8202148440.910 Why?
Proteasome Endopeptidase Complex1201714980.420 Why?
Stem Cell Transplantation1201816600.370 Why?
Hematopoietic Stem Cell Transplantation2201848830.260 Why?
Neoplasm, Residual220189320.250 Why?
Von Hippel-Lindau Tumor Suppressor Protein120212930.190 Why?
Quality of Life12018106760.170 Why?
Cytotoxicity, Immunologic1202115770.160 Why?
Drug Resistance, Neoplasm3202152650.150 Why?
Lymphopoiesis120151360.140 Why?
Transplantation, Autologous1201820720.130 Why?
Killer Cells, Natural1202121910.110 Why?
Antineoplastic Agents32021138980.110 Why?
Ubiquitin-Protein Ligases1202118260.110 Why?
Disease-Free Survival2201871950.100 Why?
Adaptor Proteins, Signal Transducing1202130060.100 Why?
Immunologic Memory1201514030.090 Why?
NF-kappa B1201625530.080 Why?
Gene Expression Regulation, Neoplastic2202188950.080 Why?
Survival Rate22018136060.080 Why?
Practice Guidelines as Topic2201876310.060 Why?
Genes, Overlapping12021390.060 Why?
Cytotoxicity Tests, Immunologic120214530.060 Why?
Stem Cells1201536120.050 Why?
Cyclin-Dependent Kinase 912021770.050 Why?
Randomized Controlled Trials as Topic1201793370.050 Why?
B-Cell Maturation Antigen12020820.050 Why?
Antineoplastic Combined Chemotherapy Protocols12018111150.040 Why?
T-Lymphocytes12015103290.040 Why?
Chromatin Assembly and Disassembly120216340.040 Why?
Mice, Inbred NOD1202119740.040 Why?
Oncogene Proteins120217650.040 Why?
T-Cell Antigen Receptor Specificity12015920.040 Why?
Clinical Trials, Phase III as Topic120188030.030 Why?
Histocompatibility Antigens Class I1202115360.030 Why?
Cell Line, Tumor22021172510.030 Why?
Humans920216866630.030 Why?
Blood Donors120153540.030 Why?
Lymphocyte Count120158040.030 Why?
Transplantation Immunology120156300.030 Why?
Xenograft Model Antitumor Assays1202138810.030 Why?
Tumor Cells, Cultured1202168350.030 Why?
Membrane Glycoproteins1202038530.020 Why?
Genome, Human1202144580.020 Why?
Neoplasm Proteins1202039720.020 Why?
Recurrence1201881980.020 Why?
Transplantation, Homologous1201549170.020 Why?
Tumor Microenvironment1201625030.020 Why?
Genomics1202149210.020 Why?
Proteins1202162640.020 Why?
Cell Survival1201562880.020 Why?
Molecular Targeted Therapy1201628840.020 Why?
Female220213754590.020 Why?
Genome-Wide Association Study12021110190.010 Why?
Disease Progression12018132040.010 Why?
Male120183524650.010 Why?
Animals220211708490.010 Why?
Cells, Cultured12015206200.010 Why?
Cell Differentiation12015118330.010 Why?
Time Factors12018422710.010 Why?
Mice12021808030.010 Why?
Signal Transduction12016243510.010 Why?
Adult120152114000.000 Why?
Gandolfi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.